SRW Ndo1 Equilibrium Blood Sugar Support Supplement for Healthy Glucose Balance

EMIS+ Verified independent store

→

Clinical Summary: SRW Ndo¹ Equilibrium is a blood sugar support supplement formulated with a 520 mg proprietary blend of Dahlia4™ dahlia flower extract, Eriomin™ citrus lemon extra ct (70% eriocitrin), and Mulberry leaf extract (5% 1-deoxynojirimycin/DNJ) — three patented or standardised botanical ingredients targeting postprandial glucose excursion, alpha-glucosidase inhibition, and carbohydrate metabolism support. Each bottle contains 60 delayed-release vege capsules (30-day supply at 2 capsules daily), manufactured by SRW Laboratories, New Zealand, in a GMP-certified facility. Product Overview SRW Ndo¹ Equilibrium targets post-meal blood glucose management through three complementary botanical mechanisms. Mulberry leaf extract standardised to 5% 1-deoxynojirimycin (DNJ) — a naturally occurring iminosugar — competitively inhibits intestinal alpha-glucosidase enzymes that break down complex carbohydrates into glucose, thereby slowing postprandial glucose absorption. Eriomin™, a standardised lemon flavonoid extract (Citrus limon, 70% eriocitrin), has demonstrated beneficial effects on insulin sensitivity and metabolic markers in peer-reviewed human clinical trials, including a randomised controlled trial published in Phytotherapy Research. Dahlia4™ provides dahlia-derived inulin-type fructooligosaccharides that support glycaemic response modulation and prebiotic gut microbiome effects relevant to metabolic health. The Ndo¹ formulation was designed by SRW Laboratories as part of its systems-biology approach to healthy ageing, addressing the progressive decline in glucose tolerance and insulin sensitivity that accompanies ageing — a trajectory associated with increased risk of metabolic syndrome, type 2 diabetes, and cardiovascular disease per the WHO and International Diabetes Federation epidemiological data relevant to Singapore's population. Supplement Facts Attribute Details Manufacturer SRW Laboratories (Science Research Wellness), New Zealand — GMP-certified Capsule Count 60 Delayed-Release Vege Capsules (30-day supply) Serving Size 2 capsules daily, preferably with the largest meal Proprietary Blend (total) 520 mg per 2-capsule serving Dahlia4™ Dahlia Extract Patented dahlia flower extract providing inulin-type fructooligosaccharides; prebiotic and glycaemic modulation properties Eriomin™ Citrus Lemon Extract Citrus limon fruit/peel extract, standardised to 70% eriocitrin (lemon flavonoid); clinically trialled for insulin sensitivity and glucose metabolism support Mulberry Leaf Extract Standardised to 5% 1-deoxynojirimycin (DNJ); competitive alpha-glucosidase inhibitor — slows intestinal carbohydrate hydrolysis and postprandial glucose absorption Capsule Type Delayed-release vege capsule (HPMC) — vegetarian, no gelatin Allergens Free from gluten, dairy, soy, egg; no artificial colours or flavours Regulatory GMP-certified manufacturing; classified as health supplement under Singapore HSA Health Products Act; not a pharmaceutical antidiabetic agent Clinical Applications Postprandial glucose management: Mulberry leaf DNJ inhibits intestinal alpha-glucosidase (the enzyme that cleaves disaccharides into monosaccharides), reducing and delaying peak glucose absorption after carbohydrate-rich meals — a mechanism shared by the pharmaceutical drug acarbose but through a natural botanical source. Insulin sensitivity support: Eriomin™ (eriocitrin) has been evaluated in randomised controlled trials demonstrating improvements in HOMA-IR (homeostatic model assessment of insulin resistance) and fasting insulin in adults with pre-metabolic syndrome criteria. Prebiotic gut health: Dahlia4™ inulin-type fructooligosaccharides selectively promote growth of beneficial Bifidobacterium and Lactobacillus species in the gut, supporting the gut-metabolic axis relevant to insulin sensitivity and reducing systemic endotoxaemia from dysbiotic gram-negative bacteria. Healthy ageing glucose homeostasis: Age-related decline in beta-cell function and insulin receptor sensitivity begins in the fourth decade of life; Ndo¹ provides botanical support for maintaining glucose homeostasis during this trajectory, complementary to dietary carbohydrate management and regular aerobic exercise. Metabolic syndrome prevention support: For Singapore adults meeting 2–3 criteria of metabolic syndrome (abdominal obesity, elevated fasting glucose, dyslipidaemia) who are not yet on pharmacological intervention, Ndo¹ provides clinically-grounded supplement support under physician monitoring. Complementary to dietary carbohydrate management: Suitable alongside low-GI dietary patterns per Singapore HPB dietary guidelines; not a replacement for lifestyle intervention or prescription antidiabetic medications in diagnosed T2DM. Frequently Asked Questions Q: How does 1-deoxynojirimycin (DNJ) in Mulberry leaf differ from pharmaceutical alpha-glucosidase inhibitors like acarbose?A: Both DNJ and acarbose inhibit intestinal alpha-glucosidase, reducing postprandial glucose peaks. Acarbose is a prescription pharmaceutical with documented gastrointestinal side effects (flatulence, bloating) due to its potent inhibition. Mulberry leaf DNJ provides gentler, dose-dependent inhibition at supplement concentrations, with a generally milder GI side-effect profile. Ndo¹ is a health supplement — not a pharmaceutical antidiabetic — and is not intended to replace medications prescribed for type 2 diabetes. Q: When during the day should SRW Ndo¹ be taken for maximum effect?A: Given the alpha-glucosidase inhibitory mechanism of Mulberry leaf DNJ, taking Ndo¹ immediately before or with the largest carbohydrate-containing meal of the day is clinically logical to coincide with peak intestinal glucosidase activity. SRW Laboratories recommends 2 capsules daily with food; consult a healthcare practitioner for personalised timing based on meal composition and any concurrent medications. Q: Can SRW Ndo¹ be taken by individuals already prescribed metformin or other antidiabetic medications?A: Individuals on antidiabetic medications (metformin, SGLT-2 inhibitors, sulfonylureas, GLP-1 agonists, or insulin) should consult their physician before adding Ndo¹. Alpha-glucosidase inhibition from DNJ may have additive glucose-lowering effects that require adjustment of medication dosing. EMIS Asia recommends that any person with diagnosed diabetes or impaired fasting glucose use this supplement only under medical supervision. Q: Is SRW Ndo¹ suitable for long-term daily use?A: SRW Ndo¹ is formulated for continuous daily use as part of a metabolic health maintenance regimen. The botanical ingredients — dahlia inulin-type fructooligosaccharides, eriocitrin, and mulberry DNJ — have been evaluated in longer-term safety studies and human trials without clinically significant adverse effects. As with all health supplements, annual review with a healthcare practitioner is recommended, particularly for individuals with hepatic or renal impairment. Q: Is SRW Ndo¹ available for Singapore healthcare institutions or corporate wellness programmes?A: Yes. EMIS Asia supplies SRW Ndo¹ to Singapore integrative medicine clinics, preventive health programmes, and corporate wellness managers. As a health supplement under the Singapore HSA Health Products Act, Ndo¹ does not require medical device registration. Institutional pricing and standing order arrangements are available for eligible purchasers. Buy from EMIS+ — Singapore's nurse-led medical supply store.Order this product and browse our full clinical range at emis.asia. Fast local delivery, genuine stock, and clinical guidance from registered nurses. {"@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [{"@type": "Question", "name": "Q: How does 1-deoxynojirimycin (DNJ) in Mulberry leaf differ from pharmaceutical alpha-glucosidase inhibitors like acarbose?", "acceptedAnswer": {"@type": "Answer", "text": "A: Both DNJ and acarbose inhibit intestinal alpha-glucosidase, reducing postprandial glucose peaks. Acarbose is a prescription pharmaceutical with documented gastrointestinal side effects (flatulence, bloating) due to its potent inhibition. Mulberry leaf DNJ provides gentler, dose-dependent inhibition at supplement concentrations, with a generally milder GI side-effect profile. Ndo¹ is a health supplement — not a pharmaceutical antidiabetic — and is not intended to replace medications prescribed for type 2 diabetes."}}, {"@type": "Question", "name": "Q: When during the day should SRW Ndo¹ be taken for maximum effect?", "acceptedAnswer": {"@type": "Answer", "text": "A: Given the alpha-glucosidase inhibitory mechanism of Mulberry leaf DNJ, taking Ndo¹ immediately before or with the largest carbohydrate-containing meal of the day is clinically logical to coincide with peak intestinal glucosidase activity. SRW Laboratories recommends 2 capsules daily with food; consult a healthcare practitioner for personalised timing based on meal composition and any concurrent medications."}}, {"@type": "Question", "name": "Q: Can SRW Ndo¹ be taken by individuals already prescribed metformin or other antidiabetic medications?", "acceptedAnswer": {"@type": "Answer", "text": "A: Individuals on antidiabetic medications (metformin, SGLT-2 inhibitors, sulfonylureas, GLP-1 agonists, or insulin) should consult their physician before adding Ndo¹. Alpha-glucosidase inhibition from DNJ may have additive glucose-lowering effects that require adjustment of medication dosing. EMIS Asia recommends that any person with diagnosed diabetes or impaired fasting glucose use this supplement only under medical supervision."}}, {"@type": "Question", "name": "Q: Is SRW Ndo¹ suitable for long-term daily use?", "acceptedAnswer": {"@type": "Answer", "text": "A: SRW Ndo¹ is formulated for continuous daily use as part of a metabolic health maintenance regimen. The botanical ingredients — dahlia inulin-type fructooligosaccharides, eriocitrin, and mulberry DNJ — have been evaluated in longer-term safety studies and human trials without clinically significant adverse effects. As with all health supplements, annual review with a healthcare practitioner is recommended, particularly for individuals with hepatic or renal impairment."}}, {"@type": "Question", "name": "Q: Is SRW Ndo¹ available for Singapore healthcare institutions or corporate wellness programmes?", "acceptedAnswer": {"@type": "Answer", "text": "A: Yes. EMIS Asia supplies SRW Ndo¹ to Singapore integrative medicine clinics, preventive health programmes, and corporate wellness managers. As a health supplement under the Singapore HSA Health Products Act, Ndo¹ does not require medical device registration. Institutional pricing and standing order arrangements are available for eligible purchasers."}}]} Show more